tm
Seeing Is Believing
tm
Seeing Is Believing
CLRB is currently covered by 2 analysts with an average price target of $13.72. This is a potential upside of $8.94 (187.03%) from yesterday's end of day stock price of $4.78.
Cellectar Biosciences's activity chart (see below) currently has 1 price targets and 13 ratings on display. The stock rating distribution of CLRB is 90% BUY and 10% HOLD.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 225.5 days.
Highest price target for CLRB is $4, Lowest price target is $4.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 28-Mar-2024. First documented stock forecast 02-May-2019.
Currently out of the existing stock ratings of CLRB, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$20
1 years 3 months 17 days ago
(28-Mar-2024)
0/2 (0%)
$15.76 (371.70%)
Buy
$4
$2.61 (187.77%)
2 years 8 months 11 days ago
(04-Nov-2022)
1/1 (100%)
$2.11 (111.64%)
451
What is CLRB (Cellectar Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on CLRB (Cellectar Biosciences) with a proven track record?
Which analyst has the current lower performing score on CLRB (Cellectar Biosciences) with a proven track record?
Which analyst has the most public recommendations on CLRB (Cellectar Biosciences)?
Which analyst is the currently most bullish on CLRB (Cellectar Biosciences)?
Which analyst is the currently most reserved on CLRB (Cellectar Biosciences)?
